- täglichErscheinungsrhythmus
- 21 mintypische Länge
- gesternletzte Folge
The Endocrine Deep Dive covers advanced topics in endocrinology. Utilizing AI-driven synthetic audio discussions from my own study notes, each episode breaks down complex endocrine concepts.
Comprehensive Legal & Medical Disclaimer: Endocrine Deep Dives and all associated content, materials, and digital assets are produced strictly for informational and educational purposes only. The program is intended solely for healthcare providers, medical fellows, residents, and students as a supplement to their professional training.
No Physician-Patient Relationship: Listening to this podcast, accessing show notes, or interacting with the platform does not establish a physician-patient, pharmacist-patient, or any other formal professional-client relationship between the host and any listener or patient.
Not Medical Advice: The content does not constitute individualized medical advice, clinical diagnosis, or treatment recommendations. Patients and members of the general public must never use this content to guide personal healthcare decisions and must always consult a qualified, licensed physician or healthcare provider for any medical concerns.
Clinical Responsibility: Healthcare professionals listening to this program must exercise their own independent clinical judgment. The host's interpretations, study notes, and opinions reflect personal perspectives on literature and do not set an official standard of care. Clinicians bear sole responsibility for verifying all pharmacological dosing, diagnostic criteria, and treatment protocols against official institutional guidelines, current primary literature, and individual patient presentation.
Limitation of Liability: The host, creators, and associated entities disclaim any and all liability for direct, indirect, incidental, or consequential damages resulting from the use, misuse, application, or interpretation of any information presented in this podcast. Reliance on any data or opinion provided is solely at the listener's own risk.
Folgen
Familial Partial Lipodystrophy
Familial partial lipodystrophy mutations causing progressive subcutaneous fat loss from the extremities and trunk with paradoxical fat accumulation in the face and neck. This redistribution precipitates severe insulin resistance, hypertrigl
Emil Theodor Kocher
Emil Theodor Kocher revolutionized endocrine surgery by developing meticulous, sterile, and bloodless thyroidectomy techniques. His standardized operative methods reduced surgical mortality from nearly forty percent to under one percent. Ko
Calcitonin
Calcitonin, secreted by thyroid parafollicular C cells, acts as a physiological antagonist to parathyroid hormone by suppressing osteoclastic bone resorption and renal tubular calcium reabsorption. While minor in routine adult calcium homeo
Multiple Endocrine Neoplasia Type 1
Multiple endocrine neoplasia type 1 arises from inactivating MEN1 tumor suppressor mutations, causing loss of menin function. Clinical manifestations classically feature primary hyperparathyroidism due to multiglandular hyperplasia, enterop
Crinecerfont for Steroid Reduction in CAH
This episode evaluates crinecerfont, an oral corticotropin-releasing factor type 1 receptor antagonist, for classic congenital adrenal hyperplasia. By blocking pituitary ACTH secretion independently of glucocorticoid feedback, crinecerfont
Billing Code G2211
Explore the clinical implementation of add-on code G2211 for longitudinal endocrinology outpatient care. We analyze Centers for Medicare and Medicaid Services documentation requirements, medical decision-making thresholds, and audit vulnera
Billing Code CGM/95251
Analysis and interpretation of continuous glucose monitoring data requiring at least seventy-two hours of sensor wear. This physician service focuses on evaluating glycemic variability, time in range, and nocturnal hypoglycemia to refine th
XLH and Burosumab
Adult presentations frequently masquerade as axial spondyloarthritis, early-onset osteoarthritis, or recurrent pseudofractures, evading diagnosis when chronic hypophosphatemia and renal phosphate wasting are overlooked. Transitioning from c
COCPs for PMOS
Combined oral contraceptives serve as first-line pharmacotherapy for non-fertility management. They suppress pituitary luteinizing hormone secretion to arrest ovarian theca-cell androgen synthesis while stimulating hepatic sex hormone-bindi
Mixed Meal Tolerance Test
A physiological dynamic assessment evaluating beta-cell secretory capacity and postprandial glycemic regulation under mixed macronutrient stimulation. Crucial for assessing residual endogenous insulin production via C-peptide in type 1 diab
Denosumab risks in CKD
Denosumab carries a marked risk of profound, refractory hypocalcemia in advanced chronic kidney disease, particularly stages 4 to 5D and comorbid CKD-mineral and bone disorder. In these patients, impaired calcitriol synthesis and secondary
Outpatient management of DKA
Outpatient management of diabetic ketoacidosis is inherently limited to early intervention during impending ketosis, as overt DKA with metabolic acidosis and volume depletion mandates emergency evaluation and inpatient intravenous resuscita
MACS
Mild autonomous cortisol secretion, or MACS, represents subtle hypothalamic-pituitary-adrenal axis dysregulation most frequently encountered during the workup of adrenal incidentalomas. Defined primarily by a post-one-milligram dexamethason
Familial hyperaldosteronism type 2
Familial hyperaldosteronism type 2 is an autosomal dominant form of primary aldosteronism caused predominantly by gain-of-function mutations in the CLCN2 gene, which encodes the ClC-2 voltage-gated chloride channel. These mutations lead to
Phosphopenic Osteomalacia
Phosphopenic disorders encompass conditions characterized by systemic phosphate wasting or deficiency, driven primarily by renal tubular defects, fibroblast growth factor 23 excess, or impaired gastrointestinal absorption. Key clinical mani
Calcipenic Osteomalacia
Calcipenic osteomalacia presents with low-to-normal calcium, elevated PTH, hypophosphatemia, elevated alkaline phosphatase, and low urinary calcium. Evaluation requires ruling out pseudohypocalcemia and hypomagnesemia, followed by renal fun
Calcipenic and Phosphopenic Osteomalacia
Calcipenic osteomalacia arises primarily from vitamin D deficiency or resistance, or severe calcium malabsorption, resulting in impaired mineralization due to defective intestinal calcium transport and secondary hyperparathyroidism that acc
Vitamin D Formulations
Clinical management of vitamin D deficiency requires distinguishing between native secosteroids and hydroxylated metabolites based on individual metabolic clearance and organ function. Cholecalciferol maintains superior pharmacokinetics ove
Teprotumumab
Teprotumumab is a fully human monoclonal antibody targeting the insulin-like growth factor 1 receptor, revolutionizing the medical management of active thyroid eye disease. By blocking receptor signaling on orbital fibroblasts, it reduces i
Fragile X Premutation
Fragile X premutation carriers harbor FMR1 allele expansions containing fifty-five to two hundred CGG repeats, predisposing them to distinct clinical syndromes driven by elevated toxic messenger ribonucleic acid levels. Adult carriers face
Bone Turnover Markers
PODCAST SUMMARY: Bone turnover markers provide dynamic, real-time biochemical assessment of skeletal metabolism by quantifying bone formation through serum osteocalcin and procollagen type 1 N-terminal propeptide alongside bone resorption v
Hyperparathyroidism: Surgery vs Bisphosphonates Timing
Primary hyperparathyroidism management hinges on distinguishing symptomatic from asymptomatic disease and assessing surgical candidacy according to established biochemical and densitometric thresholds. Parathyroidectomy remains the only cur
Persistent Post Thyroidectomy Tingling Despite Normocalcemia
Post thyroidectomy hypocalcemia typically presents with perioral tingling and neuromuscular irritability driven by transient or permanent hypoparathyroidism. Early clinical identification relies on eliciting Chvostek and Trousseau signs alo
Real world use of Palopegteriparatide
A long-acting parathyroid hormone prodrug engineered for continuous parathyroid hormone receptor type 1 activation via physiologic autocleavage. Once-daily administration maintains stable serum calcium and phosphate levels while lowering ur
Everything About Palopegteriparatide
Palopegteriparatide is a long-acting prodrug of parathyroid hormone designed for once-weekly subcutaneous administration in hypoparathyroidism. By providing sustained physiological systemic exposure, it normalizes serum calcium and urinary
Levothyroxine Interactions and More and More
Levothyroxine absorption is highly vulnerable to gastrointestinal disruptions and concurrent ingestions. Common culprits include calcium carbonate, ferrous sulfate, proton pump inhibitors, and fiber supplements, which bind the hormone or al
Hunt for the Elusive Neuropeptides
The intense rivalry between Roger Guillemin and Andrew Schally revolutionized neuroendocrinology through the isolation of hypothalamic releasing hormones. Following their initial collaboration at Baylor University, the two researchers pursu
IPSS Case Studies
Inferior petrosal sinus sampling differentiates Cushing disease from ectopic adrenocorticotropic hormone secretion using simultaneous petrosal and peripheral venous hormone measurements. A normal pituitary magnetic resonance imaging does no
Inferior petrosal sinus sampling
Inferior petrosal sinus sampling is the diagnostic gold standard for localizing the source of adrenocorticotropic hormone dependent Cushing syndrome when pituitary imaging is non diagnostic or discordant. The procedure relies on comparing s
Testing for 1-25 dihydroxy Vitamin D
Assessing nutritional vitamin D status requires measuring 25-hydroxyvitamin D, as serum 1,25-dihydroxyvitamin D is tightly regulated by parathyroid hormone, calcium, and phosphate, often remaining normal or paradoxically elevated in severe
